Non categorizzato Moderna rises 4% on optimism about RSV jab Gennaio 18, 2023 0 commenti Moderna Inc.’s stock rose above 4% on Wednesday, as investors drew optimism from the company’s announcement on the efficiency of the vaccine for respiratory syncytial virus or RSV. According … About the author:
Get involved!
Comments